Locomotion adaptation deficits in older adults with mild cognitive impairment and Alzheimers disease
患有轻度认知障碍和阿尔茨海默病的老年人的运动适应缺陷
基本信息
- 批准号:10754072
- 负责人:
- 金额:$ 42.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:Activities of Daily LivingAdverse eventAerobicAffectAgeAlzheimer&aposs DiseaseBiological MarkersClinical TrialsCognitionCognitiveCognitive deficitsCommunitiesComplexDisease ProgressionElderlyEquilibriumEvaluationExerciseFall preventionFeasibility StudiesFutureGaitGait abnormalityGait speedGoalsHumanImpaired cognitionImpairmentIndividualInterventionKnowledgeLengthLiteratureLocomotionLocomotor adaptationMeasuresMotorMovementOutcomeParticipantPatientsPatternPerformancePersonsPhysical FunctionProcessPublishingQuality of lifeResearchResourcesScienceStandardizationStimulusTelephoneTestingTimeTrainingWalkingburden of illnesscognitive functioncognitive taskcohortcomparison groupenvironmental changeexercise interventionfallsflexibilitygait rehabilitationimprovedimproved mobilityinnovationmild cognitive impairmentmotor impairmentmultimodal dataneuralneuropathologypost strokesensory feedbacktherapeutic targetwalking intervention
项目摘要
PROJECT ABSTRACT
Community walking function requires complex motor coordination, sensory feedback, dynamic balance,
adaptation to changing environmental stimuli, while also attending to tasks such as crossing a street or talking
over the phone. Unfortunately, cognitive dysfunction, the hallmark of mild cognitive impairments (MCI) and
Alzheimer’s Disease (AD), directly impacts the cognitive-motor neural resources available to carry out such
activities of daily living. The rigor of previous research shows that compared to healthy older adults (HOA),
people with MCI and AD walk slower, fall more, and have deficits in gait performance. Notably, gait
disturbances and changes in gait variability often precede cognitive decline. Thus, our overall goal is to
understand the effects of MCI and AD on gait function and locomotor flexibility, and the inter-relationships with
cognitive impairments. Locomotor adaptation is a fundamentally important process that enables humans to
flexibility respond to environmental demands, enabling normal community walking function. Split-belt walking is
a standardized, robust, well studied paradigm for quantifying capacity for locomotor adaptation, with potential
implications for walking function and fall prevention. Despite a large body of literature on split-belt adaptation in
individuals of multiple ages and neuro-pathologies, surprisingly, split-belt adaptation has not been assessed in
MCI and AD. A previous study showed reduction in the rate of split-belt adaptation when able-bodied
participants were distracted by a cognitive task, suggesting that adaptation processes interact with cognitive
functions. Another study showed multiple sessions of split-belt walking improved mobility outcomes post-
stroke, suggesting its potential as an exercise intervention. However, there is a knowledge gap regarding if and
how split-belt adaptation relates to cognitive deficits and walking function in individuals with MCI and AD. The
current R21 will build upon MPI Kesar and Nocera’s new published study that provides the first preliminary
evidence that split-belt adaptation is significantly impaired in people with MCI and AD compared to HOA. Our
premise is that in people with MCI and AD, reduced capacity for locomotor adaptation is a fundamental but
poorly understood mechanism that can be a sensitive biomarker of cognitive-motor impairments, and an
important therapeutic target for exercise-based interventions. Here, we propose the first comparison of split-
belt adaptation, in conjunction with comprehensive assessments of gait and cognitive function, in MCI, AD, and
HOA. We propose a unique combination of cross-sectional between-group comparisons (Aim 1) and repeated-
measures longitudinal time-point comparisons of disease progression (Aim 2). Aim 3 is a preliminary feasibility
study to guide future clinical trials on split-belt aerobic walking exercise interventions in MCI and AD. Further,
in parallel with locomotor adaptation (not previously studied), we will also evaluate walking function (gait
speed, gait endurance, mobility outcomes), gait performance (step length, gait variability, stride time), and
cognition in the same participant cohort, generating an innovative, rich, multi-modal dataset.
项目摘要
社区步行功能需要复杂的运动协调、感觉反馈、动态平衡、
适应不断变化的环境刺激,同时还要注意过马路或说话等任务
不幸的是,认知功能障碍是轻度认知障碍(MCI)的标志,
阿尔茨海默病 (AD) 直接影响可用于执行此类操作的认知运动神经资源
先前研究的严谨性表明,与健康老年人 (HOA) 相比,
患有 MCI 和 AD 的人行走速度较慢,跌倒次数较多,并且步态表现有缺陷。
步态变异的干扰和变化通常先于认知能力下降。因此,我们的总体目标是
了解 MCI 和 AD 对步态功能和运动灵活性的影响,以及与
认知障碍是一个非常重要的过程,它使人类能够
灵活应对环境需求,实现正常的社区步行功能。
一个标准化的、稳健的、经过充分研究的范式,用于量化运动适应能力,具有潜力
尽管有大量关于分叉带适应的文献。
令人惊讶的是,不同年龄和神经病理学的个体尚未对裂带适应进行评估
MCI 和 AD 之前的一项研究表明,当身体健全时,分带适应率会降低。
参与者被认知任务分散了注意力,这表明适应过程与认知相互作用
另一项研究表明,多次分带行走可以改善术后的活动能力。
中风,表明其作为运动干预的潜力。然而,关于是否和是否以及是否存在知识差距。
分裂带适应与 MCI 和 AD 患者的认知缺陷和步行功能有关。
当前的 R21 将建立在 MPI Kesar 和 Nocera 新发表的研究的基础上,该研究提供了第一个初步研究
有证据表明,与 HOA 患者相比,MCI 和 AD 患者的分裂带适应能力明显受损。
前提是,对于患有 MCI 和 AD 的人来说,运动适应能力的降低是一个基本但
知之甚少的机制可能是认知运动障碍的敏感生物标志物,并且
在此,我们提出了基于运动的干预措施的第一个比较。
腰带适应,结合步态和认知功能的综合评估,用于 MCI、AD 和
HOA。我们提出了横断面组间比较(目标 1)和重复的独特组合。
测量疾病进展的纵向时间点比较(目标 3)是初步可行性。
研究指导未来关于 MCI 和 AD 分带式有氧步行运动干预的临床试验。
与运动适应(以前未研究过)并行,我们还将评估步行功能(步态
速度、步态耐力、移动结果)、步态表现(步长、步态变异性、步幅时间),以及
同一参与者群体中的认知,生成创新的、丰富的、多模式的数据集。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Trisha Kesar其他文献
Trisha Kesar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Trisha Kesar', 18)}}的其他基金
Biomechanical and neural mechanisms of post-stroke gait training
中风后步态训练的生物力学和神经机制
- 批准号:
10219315 - 财政年份:2019
- 资助金额:
$ 42.31万 - 项目类别:
Biomechanical and neural mechanisms of post-stroke gait training
中风后步态训练的生物力学和神经机制
- 批准号:
10461031 - 财政年份:2019
- 资助金额:
$ 42.31万 - 项目类别:
Cortical and spinal correlates of stroke gait rehabilitation
中风步态康复的皮质和脊髓相关性
- 批准号:
8679710 - 财政年份:2014
- 资助金额:
$ 42.31万 - 项目类别:
Cortical and spinal correlates of stroke gait rehabilitation
中风步态康复的皮质和脊髓相关性
- 批准号:
9093831 - 财政年份:2014
- 资助金额:
$ 42.31万 - 项目类别:
相似国自然基金
基于机器学习和影像学多参数融合的心血管不良事件风险预测模型研究
- 批准号:82370513
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
GNB3联合光谱CT冠周脂肪组学预警ACS后心血管不良事件的模型构建
- 批准号:82302186
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于效用错位视角的医疗不良事件管理政策的引导体系优化研究
- 批准号:72304012
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于人工智能和多模态信息预测复杂下肢动脉病变术后不良事件的算法机制研究
- 批准号:82370499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于真实世界数据的药物相互作用相关不良事件风险评估及其管理策略研究
- 批准号:72304010
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Advancing Capacity to Integrate Exercise into the Care of Older Cancer Survivors: The ACES initiative to establish guidelines, feasibility and best practices for research in cancer and aging
提高将运动纳入老年癌症幸存者护理的能力:ACES 倡议为癌症和衰老研究制定指南、可行性和最佳实践
- 批准号:
10739672 - 财政年份:2023
- 资助金额:
$ 42.31万 - 项目类别:
PHD2 mediated loss of hypoxia signaling limits skeletal muscle regeneration and exercise response in aging
PHD2介导的缺氧信号丧失限制了骨骼肌再生和衰老过程中的运动反应
- 批准号:
10657095 - 财政年份:2023
- 资助金额:
$ 42.31万 - 项目类别:
Understanding the Barriers to Physical Activity in Pediatric Pulmonary Hypertension in Order to Design Effective Home-based Exercise Programs
了解小儿肺动脉高压患者体力活动的障碍,以便设计有效的家庭锻炼计划
- 批准号:
10661484 - 财政年份:2021
- 资助金额:
$ 42.31万 - 项目类别:
Understanding the Barriers to Physical Activity in Pediatric Pulmonary Hypertension in Order to Design Effective Home-based Exercise Programs
了解小儿肺动脉高压患者体力活动的障碍,以便设计有效的家庭锻炼计划
- 批准号:
10453550 - 财政年份:2021
- 资助金额:
$ 42.31万 - 项目类别:
A randomized placebo-controlled trial of methylphenidate in Veterans with a diagnosis of post traumatic stress disorder and recent cerebral stroke.
在诊断为创伤后应激障碍和近期脑卒中的退伍军人中进行哌甲酯的随机安慰剂对照试验。
- 批准号:
10257285 - 财政年份:2021
- 资助金额:
$ 42.31万 - 项目类别: